Our studies corroborate earlier findings where mitochondria-targeting drugs, along with conventional cancer therapeutics like paclitaxel/cisplatin, efficiently induced cytotoxicity through mitochondrial damage and release of cytochrome C [31]. The gene discussed is CYCS; the disease is cancer.